Phocas Financial Corp.
- SEC CIK
- 0001356783
- Latest filing
- Jul 30, 2026
AMRX holding history
Amneal Pharmaceuticals, Inc. in every 13F filed by Phocas Financial Corp., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AMRX overviewAll 13F holders of AMRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 819,476
- Value
- $14.2M
- % of portfolio
- 2.0%
- Quarters held
- 11
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 819,476 | $14.2M | 2.0% | −183,188−18.3% | Reduced | Holders |
| Q1 2026 | 1,002,664 | $12.5M | 2.0% | −280,310−21.8% | Reduced | Holders |
| Q4 2025 | 1,282,974 | $16.2M | 2.1% | −2,810−0.2% | Reduced | Holders |
| Q3 2025 | 1,285,784 | $12.9M | 1.7% | +26,220+2.1% | Added | Holders |
| Q2 2025 | 1,259,564 | $10.2M | 1.5% | +1860.0% | Added | Holders |
| Q1 2025 | 1,259,378 | $10.6M | 1.6% | −71,035−5.3% | Reduced | Holders |
| Q4 2024 | 1,330,413 | $10.5M | 1.4% | +315,223+31.1% | Added | Holders |
| Q3 2024 | 1,015,190 | $8.45M | 1.2% | −63,485−5.9% | Reduced | Holders |
| Q2 2024 | 1,078,675 | $6.85M | 1.0% | +381,592+54.7% | Added | Holders |
| Q1 2024 | 697,083 | $4.22M | 0.6% | −17,807−2.5% | Reduced | Holders |
| Q4 2023 | 714,890 | $4.34M | 0.6% | +714,890 | New | Holders |